Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Estrategias de vanguardia para la atención del VIH en México: Una mujer en edad fértil

En este vlog de caso clínico, escuche las opiniones de los expertos y las recomendaciones basadas en guías sobre las consideraciones para optimizar el TAR en una paciente en edad fértil con supresión virológica en México.
Luis E. Soto-Ramirez, MD
Released: May 31, 2022

Information on this Educational Activity

Faculty

Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramirez, MD, has disclosed that he has received consulting fees from Gilead Sciences, GlaxoSmithKline, Merck, and ViiV Healthcare and fees for non-CME/CE services from Gilead Sciences, Janssen, and Merck.

Program Medium

This program has been made available online.

Related Content

Expert insights on HIV PrEP medications, guideline updates, and solutions to uptake barriers, from Dr Gregory Huhn and Clinical Care Options (CCO)

Gregory Huhn, MD, MPHTM Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: August 12, 2022 Expired: August 11, 2023

Clinical Care Options (CCO) commentary from Dr Darrell Tan on the dosing options for long-acting injectable cabotegravir plus rilpivirine for HIV treatment

Babafemi Taiwo, MBBS
Program Director
Darrell H. S. Tan, MD, FRCPC, PhD
Released: August 12, 2022

Gregory Huhn, MD, MPHTM Released: August 12, 2022

Clinical Care Options (CCO) expert Carolyn Chu, MD, MSc, discusses how to improve HIV pre-exposure prophylaxis accessibility and availability for PWID

person default Carolyn Chu, MD, MSc, FAAFP, AAHIVS Released: August 12, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings